Related Experiment Videos
Analysis of a variant form of platelet glycoprotein (GP) IIb: a second patient with abnormal molecular weight GPIIb
1Department of Protein Biochemistry, Kurume University, Fukuoka, Japan.
Abstract:
In 1988, we reported a thrombasthenic patient whose platelets contained an abnormal molecular weight GPIIb (Blood, 71, 915, 1988). Here we describe another patient whose platelets contain a variant GPIIb with properties similar to the previously reported abnormal GPIIb. This patient has a small amount of the abnormal GPIIb and was suggested to be a heterozygote characterized by deficient and abnormal GPIIb genes. The abnormal GPIIb was suggested to be related to the precursor form of GPIIb because the molecular weights of both proteins are the same. The abnormal GPIIb may lack a peptide region around the cleavage site of the two chains, as suggested from its lack of reactivity towards antibodies against these epitopes.
Insights
Researchers identified a new patient with thrombasthenia, exhibiting abnormal glycoprotein IIb (GPIIb) in platelets. This finding suggests a potential genetic link and offers insights into GPIIb protein structure and function.
Area of Science:
- Hematology
- Molecular Biology
- Biochemistry
Background:
- Thrombasthenia is a bleeding disorder characterized by platelet dysfunction.
- Glycoprotein IIb (GPIIb) is a critical protein complex in platelet aggregation.
Observation:
- A patient with thrombasthenia presented platelets with an abnormal molecular weight GPIIb, similar to a previously reported case.
- This patient showed a low level of the abnormal GPIIb, suggesting heterozygosity for deficient and abnormal GPIIb genes.
Findings:
- The abnormal GPIIb shares the same molecular weight as the precursor form, indicating a potential relationship.
- The abnormal GPIIb's lack of reactivity to specific antibodies suggests a missing peptide region near the cleavage site.
Implications:
- This study deepens the understanding of GPIIb gene mutations and their impact on protein structure.
- Findings may contribute to improved diagnostics and therapeutic strategies for thrombasthenia and related bleeding disorders.